Roche Holding is trading at CHF 370.90, up 3.09% at the October 14 close, as healthcare stocks rallied after UnitedHealth beat Q3 earnings expectations and raised its 2026 profit outlook.
- Reporting also noted investors rotated toward healthcare amid inflation concerns.
- Roche’s October 13 obesity-drug licensing deal with Rona was notable company news, but reporting does not establish it caused this session’s gain.